07/11/2025
4:14 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
3:21 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
4:06 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:08 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:08 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:09 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:25 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:08 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:08 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:09 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2025
4:12 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ONC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BeOne Medicines and its competitors with MarketBeat's FREE daily newsletter. |
06/12/2025
4:49 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:51 PM | Ball Titus B. (Reporting)
BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:38 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:39 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:42 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:44 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:45 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:15 PM | Ball Titus B. (Reporting)
BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
3:54 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:13 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
3:16 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
11:15 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
05/27/2025
3:52 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POSASR | |
05/27/2025
3:52 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POSASR | |
05/27/2025
3:26 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POS AM | |
05/27/2025
7:35 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K12G3 | |
05/26/2025
11:15 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Riva Alessandro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:46 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
BRANDICOURT OLIVIER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:47 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:41 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
HOOPER ANTHONY C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:42 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Dugan Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:45 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
4:37 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:53 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Capital International Investors (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
5:04 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
5:09 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
3:09 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:26 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
04/16/2025
4:12 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:21 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
5:12 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form ARS | |
04/07/2025
5:03 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEF 14A | |
04/07/2025
5:07 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEFA14A | |
04/01/2025
3:27 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
3:53 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:51 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
3:43 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:51 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144/A | |
03/10/2025
3:19 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:08 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEFA14A | |
03/09/2025
11:15 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
03/10/2025
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 424B3 | |
03/07/2025
7:17 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:26 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:19 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:20 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:22 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:24 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:14 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
4:22 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:48 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:07 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:30 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SCHEDULE 13D/A | |
03/03/2025
8:31 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:30 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:49 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
8:43 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:40 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:28 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K/A | |
02/28/2025
5:15 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form S-4/A | |
02/27/2025
5:04 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
5:12 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
3:23 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:24 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Lee Chan Henry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
5:12 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:29 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
3:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:02 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:08 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K/A | |
01/07/2025
3:18 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
5:05 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
4:02 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:18 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:25 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:30 PM | BAKER BROS. ADVISORS LP (Filed by)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form SC 13D/A | |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
12/10/2024
7:19 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:26 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:48 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
8:48 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
8:45 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
3:31 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:23 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:23 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
